{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:36:37Z","timestamp":1778664997040,"version":"3.51.4"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic>\n                      species is a common pathogen in lung transplant patients. However, existing clinical standards rely on a complex constellation of clinical, radiological, and microbiologic criteria with limited sensitivity to differentiate between invasive\n                      <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic>\n                      infection and colonization. We therefore tested whether a molecular measure of allograft injury\u2014donor-derived cell-free DNA (dd-cfDNA)\u2014better identifies invasive aspergillosis compared with current guidelines-based classification.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>\n                      This multicenter prospective cohort study included lung transplant patients. Microbiological isolates of\n                      <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic>\n                      were matched with temporally available dd-cfDNA data. Invasive aspergillosis was defined either by clinical criteria using published guidelines or by molecular criteria (dd-cfDNA &gt;1%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Among 177 lung transplant recipients, 33 patients had 34 positive\n                      <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic>\n                      results. Of those, 16 met clinical criteria and 19 met molecular criteria of invasive aspergillosis. Eighteen met clinical criteria and 15 met molecular criteria for colonization. Patients who met molecular criteria for invasive disease had significantly reduced chronic lung allograft dysfunction-free survival (hazard ratio, 10.5; 95% confidence interval, 1.34-82.1;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.03) compared with the patients with colonization. In contrast, classification based on clinical criteria was not associated with worse outcomes (hazard ratio, 2.3; 95% confidence interval, 0.7-7.8;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.19).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Invasive aspergillosis, as defined by molecular criteria (dd-cfDNA &gt;1%), was associated with reduced chronic lung allograft dysfunction-free survival in lung transplant recipients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001894","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T19:00:14Z","timestamp":1765911614000},"page":"e1894","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Plasma Cell-free DNA Associated With Risk of Mortality and Chronic Lung Allograft Dysfunction Among Lung Transplant Recipients With Aspergillus"],"prefix":"10.1097","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6616-7127","authenticated-orcid":false,"given":"Yasir","family":"Hamad","sequence":"first","affiliation":[{"name":"Pulmonary, Critical Care, and Sleep Division, Department of Medicine, University of Minnesota School of Medicine, Minneapolis, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joby","family":"Mathew","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Temesgen","family":"Andargie","sequence":"additional","affiliation":[{"name":"Division of Intramural Research, Laboratory of Applied Precision Omics, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD."},{"name":"Division of Intramural Research, Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven D.","family":"Nathan","sequence":"additional","affiliation":[{"name":"Division of Intramural Research, Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."},{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, Advanced Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyesik","family":"Kong","sequence":"additional","affiliation":[{"name":"Division of Intramural Research, Laboratory of Applied Precision Omics, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD."},{"name":"Division of Intramural Research, Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon Kyoo","family":"Jang","sequence":"additional","affiliation":[{"name":"Division of Intramural Research, Laboratory of Applied Precision Omics, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD."},{"name":"Division of Intramural Research, Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pali","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD."},{"name":"Division of Intramural Research, Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shambhu","family":"Aryal","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, Advanced Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9380-9161","authenticated-orcid":false,"given":"Sean","family":"Agbor-Enoh","sequence":"additional","affiliation":[{"name":"Division of Intramural Research, Laboratory of Applied Precision Omics, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD."},{"name":"Division of Intramural Research, Genomic Research Alliance for Transplantation (GRAfT), Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"R1-20251216","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ccm.2017.04.011","article-title":"Fungal infections after lung transplantation.","volume":"38","author":"Kennedy","year":"2017","journal-title":"Clin Chest Med"},{"key":"R2-20251216","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3390\/pathogens12050694","article-title":"Diagnosis and treatment of fungal infections in lung transplant recipients.","volume":"12","author":"Escamilla","year":"2023","journal-title":"Pathogens"},{"key":"R3-20251216","doi-asserted-by":"crossref","first-page":"e13544","DOI":"10.1111\/ctr.13544","article-title":"Invasive Aspergillosis in solid-organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.","volume":"33","author":"Husain","year":"2019","journal-title":"Clin Transpl"},{"key":"R4-20251216","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R5-20251216","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.healun.2017.01.050","article-title":"Clinical risk factors for invasive Aspergillosis in lung transplant recipients: results of an international cohort study.","volume":"36","author":"Aguilar","year":"2018","journal-title":"J Heart Lung Transpl"},{"key":"R6-20251216","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients.","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R7-20251216","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R8-20251216","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.healun.2021.04.009","article-title":"Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study.","volume":"40","author":"Jang","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R9-20251216","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.healun.2018.01.1305","article-title":"Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: evidence from cell-free DNA analysis.","volume":"37","author":"Agbor-Enoh","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R10-20251216","doi-asserted-by":"crossref","first-page":"e1411","DOI":"10.1097\/TXD.0000000000001411","article-title":"Assessment of dd-cfDNA levels in clinically stable lung allograft recipients beyond the initial 2 y posttransplant.","volume":"8","author":"Trindade","year":"2022","journal-title":"Transpl Direct"},{"key":"R11-20251216","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/jalm\/jfac115","article-title":"Biological variation of donor-derived cell-free DNA in stable lung transplant recipients [published correction appears in].","volume":"8","author":"Keller","year":"2023","journal-title":"J Appl Lab Med"},{"key":"R12-20251216","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1164\/rccm.202305-0798OC","article-title":"Higher molecular injury at diagnosis of acute cellular rejection increases the risk of lung allograft failure: a clinical trial.","volume":"209","author":"Keller","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R13-20251216","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.healun.2021.05.012","article-title":"Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury.","volume":"40","author":"Bazemore","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R14-20251216","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment\u2014a consensus report from the pulmonary council of the ISHLT.","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R15-20251216","doi-asserted-by":"crossref","first-page":"e147610","DOI":"10.1172\/jci.insight.147610","article-title":"Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury.","volume":"6","author":"Andargie","year":"2021","journal-title":"JCI Insight"},{"key":"R16-20251216","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.healun.2017.05.026","article-title":"Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation.","volume":"36","author":"Agbor-Enoh","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R17-20251216","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/CMR.18.1.44-69.2005","article-title":"Aspergillus infections in transplant recipients.","volume":"18","author":"Singh","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"R18-20251216","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1378\/chest.103.1.59","article-title":"Impairment of bronchial mucociliary clearance in long-term survivors of heart\/lung and double-lung transplantation.","volume":"103","author":"Herve","year":"1993","journal-title":"Chest"},{"key":"R19-20251216","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1053-2498(02)00477-1","article-title":"Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management.","volume":"22","author":"Singh","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"R20-20251216","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1097\/TXD.0000000000001128","article-title":"Risk of lung allograft dysfunction associated with Aspergillus infection.","volume":"7","author":"Le Pavec","year":"2021","journal-title":"Transpl Direct"},{"key":"R21-20251216","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R22-20251216","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/jof7020076","article-title":"Review of pharmacologic considerations in the use of azole antifungals in lung transplant recipients.","volume":"7","author":"Klatt","year":"2021","journal-title":"J Fungi (Basel)"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T19:00:17Z","timestamp":1765911617000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001894","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]}}}